A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
Conditions: Colorectal Neoplasia Interventions: Drug: Omeprazole; Drug: Aspirin Sponsors: University of Michigan Rogel Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Conditions: Intracranial Atherosclerosis; Cognitive Impairment; Cerebrovascular Event Interventions: Drug: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin; Procedure: Endovascular therapy,Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin Sponsors: Anhui Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke
Conditions: Ischemic Stroke, Acute Interventions: Drug: Early Dual Antiplatelet Therapy; Drug: Placebo Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Aspin: neurosurgical aspirin intervention prognostic study — perioperative continuation versus discontinuation of aspirin in lumbar spinal surgery, a randomized controlled, noninferiority trial
AbstractRationaleAspirin is typically discontinued in cranial and spinal surgery because of the increased risk of hemorrhagic complications, but comes together with the risk of resulting in an increase of cardiac and neurologic thrombotic perioperative events.ObjectiveThe aim of this study is to investigate the non-inferiority of perioperative continuation of aspirin patients undergoing low complex lumbar spinal surgery, compared with the current policy of perioperative discontinuation of aspirin.Study designA randomized controlled trial with two parallel groups of 277 cases (554 in total).Study populationPatients undergoi...
Source: Trials - February 29, 2024 Category: Research Source Type: clinical trials
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Conditions: Coronary Artery Disease; Atherosclerosis, Coronary Interventions: Drug: Statin; Drug: Aspirin tablet; Drug: Nexlizet; Drug: LEQVIO; Drug: Vascepa; Drug: Jardiance; Drug: Colchicine Sponsors: University of Louisville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Treatment With Aspirin After Preeclampsia: TAP Trial
Conditions: Hypertensive Disorder of Pregnancy; Pre-Eclampsia; Hypertension; Eclampsia; Gestational Hypertension; Cardiovascular Diseases; Toxemia; Pregnancy Complications; Vascular Diseases; Hypertension, Pregnancy Induced; Hypertension;Pre-Eclamptic Interventions: Drug: Low-dose aspirin; Drug: Placebo Sponsors: Alisse Hauspurg; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Low Dose Aspirin for Prevention of Early Pregnancy Loss
Conditions: Pre-Eclampsia Interventions: Drug: Aspirin Sponsors: Egymedicalpedia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome
Conditions: Myocardial Infarction; Acute Coronary Syndrome Interventions: Drug: Low-dose aspirin Sponsors: Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
Conditions: Ischemic Stroke; Intracranial Arteriosclerosis; Secondary Prevention; Antiplatelet Drug Interventions: Drug: clopidogrel for 90 days combined with aspirin for 90 days; Drug: clopidogrel for 30 days combined with aspirin for 90 days Sponsors: Sichuan Provincial People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair
Conditions: Unruptured Intracranial Aneurysm; Flow Diverter; Stent-assisted Coiling; Thromboembolic Events Interventions: Drug: Tirofiban; Drug: aspirin, clopidogrel Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Aspirin Resistance in Trinidad.
Conditions: Platelet Dysfunction Due to Drugs Interventions: Drug: Aspirin 81Mg Ec Tab Sponsors: The University of The West Indies Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
DiscussionThis will be the first clinical trial to assess the best antiplatelet therapy to avoid in-stent thrombosis after MT in patients with TL.Trial registrationThe trial is registered as NCT05225961. February, 7th, 2022. (Source: Trials)
Source: Trials - January 9, 2024 Category: Research Source Type: clinical trials
The Effect of Aspirin on Recurrent Acute Pancreatitis
Conditions: Recurrent Acute Pancreatitis; Prevention; Aspirin Interventions: Drug: 100mg aspirin Sponsors: Air Force Military Medical University, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Conditions: Chronic Total Occlusion Interventions: Procedure: Percutaneous coronary intervention; Drug: Short dual Aspirin/Clopidogrel therapy; Other: Long dual Aspirin/Clopidogrel therapy; Other: Follow-up visit at 1 month; Other: Follow-up visit at 6 months; Other: Follow-up visit at 12 months Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Daily Aspirin Treatment After Preeclampsia
Conditions: Preeclampsia Interventions: Drug: Aspirin; Drug: Placebo Sponsors: Anna Stanhewicz, PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
